Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA)

References

• Nakao M, Senda Y. An epidemiological investigation of hospital infections caused by MRSA and their prevention. Kaw J Med Welfare 2006;12:1–11
   Google Scholar
• Walsh FM, Amyes SGB. Microbiology and drug resistance mechanisms of fully resistant pathogens. Curr Opin Microbiol 2004;7:439–44
   PubMed Web of Science ®Google Scholar
• Charles PGP, Grayson ML. The dearth of new antibiotic development: why we should be worried and what we can do about it. Med J Aust 2004;181:549–53
   PubMed Web of Science ®Google Scholar
• Jorge SD, Masunari A, Rangel-Yagui CO, et al. Design, synthesis, antimicrobial activity and molecular modeling studies of novel benzofuroxan derivatives against Staphylococcus aureus. Bioorg Med Chem 2009;17:3028–36
   PubMed Web of Science ®Google Scholar
• Masunari A, Tavares LC. A new class of nifuroxazide analogues: synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus. Bioorg Med Chem 2007;15:4229–36
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharm Toxicol Methods 2000;44:301–12
   PubMed Web of Science ®Google Scholar
• Artursson P, Borchard RT. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res 1997;14:1655–8
   PubMed Web of Science ®Google Scholar
• Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991;175:880–5
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S. Cell culture-based models for intestinal permeability: a critique. Drug Discov Today 2005;10:335–43
   PubMed Web of Science ®Google Scholar
• Irvine JD, Takahashi L, Lockhart K, et al. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci 1999;88:28–33
   PubMed Web of Science ®Google Scholar
• Lentz KA, Hayashi J, Lucisano LJ, et al. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and a application to the biopharmaceutics classification system. Int J Pharm 2000;200:41–51
   PubMed Web of Science ®Google Scholar
• Rubas W, Jezyk N, Grass GM. Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res 1993;10:113–18
   PubMed Web of Science ®Google Scholar
• Kim D-C, Burton PS, Borchard RT. A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa. Pharm Res 1993;10:1710–14
   PubMed Web of Science ®Google Scholar
• Conradi RA, Wilkinson KF, Rush BD, et al. In vitro/in vivo models for peptide oral absorption: comparison of Caco-2 cell permeability with rat intestinal absorption of rennin inhibitory peptides. Pharm Res 1993;10:1790–2
   PubMed Web of Science ®Google Scholar
• Rubas W, Villagran J, Cromwell M, et al. Correlation of solute flux across Caco-2 monolayers and colonic tissue in vitro. S.T.p. Pharma Sci 1995;5:93–7
   Web of Science ®Google Scholar
• Ginski JM, Polli JE. Prediction of dissolution/absorption relationships from a dissolution/Caco-2 system. Int J Pharm 1999;177:117–25
   PubMed Web of Science ®Google Scholar
• Gonçalves JE, Souza J, Storpirtis S. Avaliação da permeabilidade de fármacos empregando culturas celulares. In: Storpirtis S, Gonçalves JE, Chiann C, Gai MN, eds. Biofarmacotécnica – série ciências farmacêuticas. Rio de Janeiro: Guanabara Koogan; 2009:204–11
   Google Scholar
• Yee S. In vitro permeability across Caco-2 cells (Colonic) can predict in vivo (small intestine) absorption in man: fact or myth. Pharm Res 1997;14:763–6
   PubMed Web of Science ®Google Scholar
• Biganzoli E, Cavenaghi LA, Rossi R, et al. Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics. Il Farmaco 1999;54:594–9
   PubMedGoogle Scholar
• Caekenberghe DLV, Breyssens J. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother 1987;31:1429–30
   PubMed Web of Science ®Google Scholar
• Cedillo-Rivera R, Munoz O. In vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol 1992;37:221–4
   PubMed Web of Science ®Google Scholar
• Ercefuryl®: nifuroxazide. France: Sanofi-Aventis; 2007. Medicine information Available from: http://urunler.sanofi.com.tr/Ercefuryl_kapsul_RR.pdf [last accessed 01 Jun 2014]
   Google Scholar
• Guinebault PR, Broquaire M, Thebault J, et al. Determination of nifuroxazide and furazolidone in biological fluids. Application to the comparative study of their intestinal absorption. In: Aiache JM, Hirtz J, eds. First European Congress of Biopharmaceutics and Pharmacokinetics, Paris. Eur J Drug Metabol Pharmacok 1981;8:151–8
   Google Scholar
• Labaune JP, Moreau JP, Byrne R. Comparative physiological disposition of two nitrofuran anti-microbial agents. Biopharmaceut Drug Dispos 1986;7:431–41
   PubMed Web of Science ®Google Scholar
• Buzard JA, Conklin JD, O’Keefe E, et al. Studies on the absorption, distribution and elimination of nitrofurantoin in the rat. J Pharmacol Exp Ther 1961;131:38–43
   PubMed Web of Science ®Google Scholar
• Shah RR, Wade G. Reappraisal of the risk/benefit of nitrofurantoin: review of toxicity and efficacy. Adverse Drug React Acute Poisoning Rev 1989;8:183–201
   PubMedGoogle Scholar
• Lin X, Skolnik S, Chen X, et al. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug Metab Dispos 2011;39:265–74
   PubMed Web of Science ®Google Scholar
• Fernandes MB, Gonçalves JE, Scotti MT, et al. Caco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against Methicillin-resistant Staphylococcus aureus (MRSA). Toxicol In Vitro 2012;26:535–40
   PubMed Web of Science ®Google Scholar
• Brasil. Resolução RDC n.899, de 29 de maio de 2003: Guia para validação de métodos analíticos e bioanalíticos
   Google Scholar
• Artursson P, Magnusson C. Epithelial transport of drug in cell culture. II: effect of extracellular calcium concentration on paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J Pharm Sci 1990;79:595–600
   PubMed Web of Science ®Google Scholar
• Hidalgo IH. Cultured intestinal epithelial cell models. In: Borchard T, Smith PL, Wilson G, eds. Models of assessing drug absorption and metabolism. New York: Plenum Press; 1996:35–50
   Google Scholar
• Behrens I, Kissel T. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharmaceut Sci 2003;19:433–42
   PubMed Web of Science ®Google Scholar
• Schmidt E, Kelly SM, Van der Walle CF. Tight junction modulation and biochemical characterization of the zonula occludens toxin C-and N-Termini. FEBS Lett 2007;58:2974–80
   Web of Science ®Google Scholar
• Rutishauser BR, Braun A, Günthert M, et al. Formation of multilayers in the Caco-2 cell culture model: a confocal laser scanning microscopy study. Pharmaceut Res 2000;17:460–5
   PubMed Web of Science ®Google Scholar
• Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2000
   Google Scholar
• Sun D, Lennernäs H, Welage LS, et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequence tags and correlation with permeability of 26 drugs. Pharm Res 2002;19:1400–16
   PubMed Web of Science ®Google Scholar
• Teksin ZS, Seo PR, Polli JE. Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers. AAPS J 2010;12:2507–21
   Web of Science ®Google Scholar
• Masungi C, Borremans C, Willems B, et al. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. J Pharm Sci 2004;93:238–41
   Google Scholar
• Wu C-Y, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a Biopharmaceutics Drug Disposition Classification System. Pharm Res 2005;22:11–23
   PubMed Web of Science ®Google Scholar
• Jang D-J, Sim T, Oh E. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption. Drug Dev Ind Pharm 2013;39:1133–41
   PubMed Web of Science ®Google Scholar
• Jain S, Kesharwani P, Tekade RK, Jain NK. One platform comparison of solubilization potential of dendrimer with some solubilizing agents. Drug Dev Ind Pharm. [Epub ahead of print]. doi:10.3109/03639045.2014.900077
   Google Scholar
• Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm 2014;40:80–91
   PubMed Web of Science ®Google Scholar
• Ferraz HG. Novas ferramentas farmacotécnicas para modular a biodisponibilidade de medicamentos. In: Storpirtis S, Gonçalves S, Chiann C, Gai MN, eds. Biofarmacotécnica – série ciências farmacêuticas. Rio de Janeiro: Guanabara Koogan; 2009:66–71
   Google Scholar